Skip to main content
AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.05
-1.06 (-1.89%)
Feb 27, 2026, 4:00 PM EST - Market closed

AnaptysBio Revenue

AnaptysBio had revenue of $76.32M in the quarter ending September 30, 2025, with 154.26% growth. This brings the company's revenue in the last twelve months to $169.47M, up 196.42% year-over-year. In the year 2024, AnaptysBio had annual revenue of $91.28M with 432.03% growth.

Revenue (ttm)
$169.47M
Revenue Growth
+196.42%
P/S Ratio
8.99
Revenue / Employee
$1,246,081
Employees
136
Market Cap
1.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202491.28M74.12M432.03%
Dec 31, 202317.16M6.87M66.78%
Dec 31, 202210.29M-52.89M-83.72%
Dec 31, 202163.18M-11.83M-15.77%
Dec 31, 202075.00M67.00M837.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 1.06B
Iovance Biotherapeutics 263.50M
Intellia Therapeutics 57.53M
EyePoint 42.34M
uniQure 15.75M
AtaiBeckley 3.02M
Revenue Rankings

ANAB News

More News